Increased pulmonary vascular resistance, right ventricular dysfunction, and reversible pulmonary vasoconstriction in type 2 pulmonary hypertension: who has it and are we missing a potential therapeutic target in patients with heart failure?-Reference-Cited by-同舟云学术

Increased pulmonary vascular resistance, right ventricular dysfunction, and reversible pulmonary vasoconstriction in type 2 pulmonary hypertension: who has it and are we missing a potential therapeutic target in patients with heart failure?

Published:2015-02-11 Issue:3 Volume:17 Page:237-238
ISSN:1388-9842
Container-title:European Journal of Heart Failure
language:en
Short-container-title:Eur J Heart Fail

Author:

Dickstein Kenneth¹

Affiliation:

1. Cardiology Division; University of Bergen, Stavanger University Hospital; Norway

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Reference6 articles.

1. Pulmonary vascular response to exercise in symptomatic heart failure with reduced ejection fraction and pulmonary hypertension;Verbrugge;Eur J Heart Fail,2015

2. PDE-5 inhibition with sildenafil improves left ventricular diastolic function, cardiac geometry and clinical status in patients with stable systolic heart failure: results of a 1-year, prospective randomized placebo controlled study;Guazzi;Circ Heart Fail,2011

3. An investigator-initiated multinational randomized controlled clinical trial: rationale and design;Cooper;Eur J Heart Fail,2013

4. Riociguat for patients with pulmonary hypertension caused by systolic left ventricular dysfunction: a phase IIb double-blind, randomized, placebo-controlled, dose-ranging hemodynamic study;Bonderman;Circulation,2013

5. Pulmonary capillary wedge pressure during exercise and long-term mortality in patients with suspected heart failure and preserved ejection fraction;Dorfs;Eur Heart J,2014

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of sildenafil on cardiac structure and function, cardiopulmonary exercise testing and health‐related quality of life measures in heart failure patients with preserved ejection fraction and pulmonary hypertension;European Journal of Heart Failure;2016-11-21

2. March 2015 at a glance;European Journal of Heart Failure;2015-03